Rchr
J-GLOBAL ID:200901082647985127   Update date: Jun. 09, 2020

Komatsu Yoshito

コマツ ヨシト | Komatsu Yoshito
Affiliation and department:
Job title: Clinical Professor, Associate Professor
Research field  (1): Tumor diagnostics and therapeutics
Research keywords  (2): Gastroenterology ,  Clinical Oncology
Research theme for competitive and other funds  (1):
  • GI oncology Cancer Chemotherapy Clinical Study
Papers (87):
  • Yamaguchi K, Komatsu Y, Satoh T, Uetake H, Yoshino T, Nishida T, Yamazaki N, Takikawa H, Morimoto T, Chosa M, Sunaya T, Hamada Y, Muro K, Sugihara K. Large-Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real-World Clinical Setting. The oncologist. 2019
  • Denda T, Sakai D, Hamaguchi T, Sugimoto N, Ura T, Yamazaki K, Fujii H, Kajiwara T, Nakajima TE, Takahashi S, Otsu S, Komatsu Y, Nagashima F, Moriwaki T, Esaki T, Sato T, Itabashi M, Oki E, Sasaki T, Sunaga Y, Ziti-Ljajic S, Brillac C, Yoshino T. Phase II trial of aflibercept with FOLFIRI as a 2nd-line treatment for Japanese patients with metastatic colorectal cancer. Cancer science. 2019
  • Kato K, Satoh T, Muro K, Yoshikawa T, Tamura T, Hamamoto Y, Chin K, Minashi K, Tsuda M, Yamaguchi K, Machida N, Esaki T, Goto M, Komatsu Y, Nakajima TE, Sugimoto N, Yoshida K, Oki E, Nishina T, Tsuji A, Fujii H, Kunieda K, Saitoh S, Omuro Y, Azuma M, Iwamoto Y, Taku K, Fushida S, Chen LT, Kang YK, Boku N. A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy re. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2018
  • Bando H, Shimodaira H, Fujitani K, Takashima A, Yamaguchi K, Nakayama N, Takahashi T, Oki E, Azuma M, Nishina T, Hironaka S, Komatsu Y, Shitara K. A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer. European journal of cancer (Oxford, England : 1990). 2018. 91. 86-91
  • Moriwaki T, Fukuoka S, Taniguchi H, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Esaki T, Makiyama C, Denda T, Satake H, Suto T, Sugimoto N, Enomoto M, Ishikawa T, Kashiwada T, Sugiyama M, Komatsu Y, Okuyama H, Baba E, Sakai D, Watanabe T, Tamura T, Yamashita K, Gosho M, Shimada Y. Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study. The oncologist. 2018. 23. 1. 7-15
more...
MISC (21):
more...
Books (2):
  • Gastrointestinal Stromal Tumor
    2019
  • Chapter 8. Gastrointestinal Stromal Tumor Adjuvant Chemotherapy: Current Practices, Efficacy and Future Directions
    2018
Education (3):
  • 2001 - 現在 Hokkaido University Graduate School of Medicine
  • 1989 - 現在 Tokyo Medical University
  • 1989 - 2001 Hokkaido University School of Medicine
Work history (9):
  • 2018/10 - 現在 Hokkaido University
  • 2011/04 - 現在 Hokkaido University
  • 2008/01 - 2011/03 Hokkaido University
  • 2007/12 - 2008/01 Hokkaido University
  • 2006 - 2007 Lecturer,Community Service Network Center
Show all
Awards (1):
  • 2003/10 - 17th Asia Pacific Cancer Conference Best Poster AWARD
Association Membership(s) (2):
American Society of Clinical Oncology ,  European Society for Medical Oncology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page